{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:39:51Z","timestamp":1764841191623,"version":"3.37.3"},"reference-count":60,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100004515","name":"The National University of Malaysia (UKM)","doi-asserted-by":"publisher","award":["DIP-2014-009"],"award-info":[{"award-number":["DIP-2014-009"]}],"id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2018,12,19]]},"abstract":"<jats:sec><jats:title\/><jats:p>Throughout the world, antidepressants (AD) and phosphodiesterase-5 inhibitors (PDE-5i) are the commonly prescribed psychopharmacological agents for treating patients with co-morbid mental health problem and sexual dysfunction (SD). The serotonergic and noradrenergic ADs, although effective, are not without any SD adverse-effects, especially erectile dysfunction (ED). ED is a failure to obtain a satisfactory erection for rewarding sexual coitus during the phases of male\u2019s sexual arousal. It is recognized as an important reason why non-adherence to treatment was observed in patients who were on AD. AD intervention caused remission to some of the pre- treatment psychopathology of ED. However, in many patients, AD potentially magnified the unwanted sexual sideeffects. This made the situation challenging for the mental health professional. These challenges are based on the complexity of ED, its etiology and the associated risk factors, which further add to its AD side-effect. The neuro-psychopharmacological basis for AD treatment selection was deliberated. Bio-psycho-social interventions are recommended at two pivotal stages. Firstly, a step should be taken for proper assessment (e.g. detailed history, psychosocial and laboratory investigations); and identify few modifiable risk factors for ED and associated mental health issues. Secondly, with guidance of an algorithm pathway, a practical intervention should include strategies such as dose reduction, augmentation or changing to an AD with lesser or no sexual adverse-effects. It is recommended that bupropion and mirtazepine to be prescribed when patients develop adverse sexual effects with serotonin selective reuptake inhibitor (SSRI), serotonin norepinephrine reuptake inhibitor (SNRI) and tricyclic antidepressant (TCA). Few suggestions which may be borne in mind are revising sexual scripts and improving sexual techniques, life-style modifications, psychotherapy and other nonpharmacological approaches which may be beneficial to both patients and their partners.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389450118666170315110902","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T04:28:13Z","timestamp":1489724893000},"page":"182-191","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Co-Morbid Erectile Dysfunction (ED) and Antidepressant Treatment in a Patient \u2013 A Management Challenge?"],"prefix":"10.2174","volume":"20","author":[{"given":"Maszaidi","family":"Zainol","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, 56000 Cheras, Kuala Lumpur, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatta","family":"Sidi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, 56000 Cheras, Kuala Lumpur, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaya","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, 56000 Cheras, Kuala Lumpur, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srijit","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, 56000 Cheras, Kuala Lumpur, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaiful Bahari","family":"Ismail","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, School of Medicine, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Hizri","family":"Hatta","sequence":"additional","affiliation":[{"name":"Zwirki I Wiguri 62, Medical University of Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najwa","family":"Baharuddin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, 56000 Cheras, Kuala Lumpur, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Ravindran","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","volume":"370","author":"Saba Moussavi S.C.","year":"2007","unstructured":"Saba Moussavi SC. Emese Verdes, Ajay Tandon, Vikram Patel, Bedirhan Ustun. Depression, chronic diseases, and decrements in health: results from the World Health Surveys.","journal-title":"Lancet"},{"key":"ref=2","unstructured":""},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"e106907","DOI":"10.1371\/journal.pone.0106907","volume":"9","author":"de Heer E.W.","year":"2014","unstructured":"de Heer EW, Gerrits MM, Beekman AT. The Association of Depression and Anxiety with Pain: A Study from NESDA.","journal-title":"PLoS One"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4088\/PCC.v03n0609","volume":"3","author":"Hirschfeld R.M.","year":"2001","unstructured":"Hirschfeld RM. The comorbidity of major depression and anxiety disorders: recognition and management in primary care.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.3390\/ijerph120809012","volume":"12","author":"Chen J.","year":"2015","unstructured":"Chen J, Chen S, Landry PF. Urbanization and mental health in china: Linking the 2010 population census with a cross-sectional survey.","journal-title":"Int J Environ Res Public Health"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/da.22376","volume":"32","author":"Hakulinen C.","year":"2015","unstructured":"Hakulinen C, Elovainio M, Pulkki-Raback L. Personality and depressive symptoms: Individual participant meta-analysis of 10 cohort studies.","journal-title":"Depress Anxiety"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/NMD.0000000000000249","volume":"203","author":"Taylor R.J.","year":"2015","unstructured":"Taylor RJ, Chae DH, Lincoln KD, Chatters LM. Extended family and friendship support networks are both protective and risk factors for major depressive disorder and depressive symptoms among African-Americans and black Caribbeans.","journal-title":"J Nerv Ment Dis"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jech-2014-205206","volume":"69","author":"Hoven H.","year":"2015","unstructured":"Hoven H, Wahrendorf M, Siegrist J. Occupational position, work stress and depressive symptoms: a pathway analysis of longitudinal SHARE data.","journal-title":"J Epidemiol Community Health"},{"key":"ref=9","unstructured":"http: \/\/wwwworldbankorg\/en\/about.April"},{"key":"ref=10","author":"Stahl S.M.","year":"2013","unstructured":"Stahl SM.","journal-title":"Stahl\u2019s Essential Psychopharmacology: Neuroscientific Basis and Applications"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4088\/JCP.v62n0201","volume":"62","author":"Stahl S.M.","year":"2001","unstructured":"Stahl SM. The psychopharmacology of sex, Part 1: Neurotransmitters and the 3 phases of the human sexual response.","journal-title":"J Clin Psychiatry"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.comppsych.2015.03.001","volume":"60","author":"Rajkumar R.P.","year":"2015","unstructured":"Rajkumar RP, Kumaran AK. Depression and anxiety in men with sexual dysfunction: a retrospective study.","journal-title":"Compr Psychiatry"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1038\/ijir.2008.47","volume":"20","author":"Jackson G.","year":"2008","unstructured":"Jackson G. Prevention of cardiovascular disease by the early identification of erectile dysfunction.","journal-title":"Int J Impot Res"},{"key":"ref=14","unstructured":""},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4065\/84.2.139","volume":"84","author":"Nehra A.","year":"2009","unstructured":"Nehra A. Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions.","journal-title":"Mayo Clin Proc"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0302-2838(03)00307-5","volume":"44","author":"Montorsi P.","year":"2003","unstructured":"Montorsi P, Montorsi F, Schulman CC. Is erectile dysfunction the \u201ctip of the iceberg\u201d of a systemic vascular disorder?","journal-title":"Eur Urol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1126\/science.847460","volume":"196","author":"Engel G.L.","year":"1977","unstructured":"Engel GL. The need for a new medical model: A challenge for biomedicine.","journal-title":"Science"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1176\/ajp.137.5.535","volume":"137","author":"Engel G.L.","year":"1980","unstructured":"Engel GL. The clinical application of the bio-psycho-social model.","journal-title":"Am J Psychiatry"},{"key":"ref=19","first-page":"47","volume":"8","author":"Boolell M.","year":"1996","unstructured":"Boolell M, Allen MJ, Ballard SA. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.","journal-title":"Int J Impot Res"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/S0022-5347(01)63299-3","volume":"159","author":"Ballard S.A.","year":"1998","unstructured":"Ballard SA, Gingell CJ, Tang K. Effects of sildenafil on the relaxation of human corpus cavernosum tissue and on the activities of cyclic nucleotide phosphodiesterase isozymes.","journal-title":"J Urol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1464-410X.1997.00206.x","volume":"79","author":"Jeremy J.Y.","year":"1997","unstructured":"Jeremy JY, Ballard SA, Naylor AM, Miller MA, Angelini GD. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum","journal-title":"Br J Urol"},{"key":"ref=22","first-page":"435","volume":"7","author":"Gresser U.","year":"2002","unstructured":"Gresser U, Gleiter CH. Erectile dysfunction: Comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.","journal-title":"Eur J Med Res"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0022-5347(01)65369-2","volume":"157","author":"Burnett A.L.","year":"1997","unstructured":"Burnett AL. Nitric oxide in the penis: Physiology and pathology.","journal-title":"J Urol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1177\/0091270005276847","volume":"45","author":"Gupta M.","year":"2005","unstructured":"Gupta M, Kovar A, Meibohm B. The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction.","journal-title":"J Clin Pharmacol"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1046\/j.0306-5251.2001.00027.x","volume":"53","author":"Nichols D.J.","year":"2002","unstructured":"Nichols DJ, Muirhead GJ, Harness JA. Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: Absolute bioavailability, food effects and dose proportionality.","journal-title":"Br J Clin Pharmacol"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1742-1241.2002.tb11296.x","volume":"56","author":"Corbin J.D.","year":"2002","unstructured":"Corbin JD, Francis SH. Pharmacology of phosphodiesterase-5 inhibitors.","journal-title":"Int J Clin Pract"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/85417","volume":"7","author":"Eichelbaum M.","year":"2001","unstructured":"Eichelbaum M, Burk O. CYP3A genetics in drug metabolism.","journal-title":"Nat Med"},{"key":"ref=28","author":"Sajjad A.","year":"2016","unstructured":"Sajjad A, Weng CY. Vision Loss in a Patient with Primary PulmonaryHypertension and Long-Term Use of Sildenafil.","journal-title":"Retinal cases"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0002-9394(00)00375-5","volume":"129","author":"Yajima T.","year":"2000","unstructured":"Yajima T, Yajima Y, Koppiker N, Grunwald JE, Laties AM. No clinically important effects on intraocular pressure after short-term administration of sildenafil citrate (Viagra).","journal-title":"Am J Ophthalmol"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/nau.22681","volume":"35","author":"Gur S.","year":"2016","unstructured":"Gur S, Yurdaarmagan B, Bayatli N, Sikka SC. Effect of short- and long-term sildenafil treatment on erectile dysfunction in rats with partial bladder outlet obstruction.","journal-title":"Neurourol Urodyn"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.ijir.3901374","volume":"17","author":"Seftel A.D.","year":"2005","unstructured":"Seftel AD, Farber J, Fletcher J. A three-part study to investigate the incidence and potential etiologies of tadalafil-associated back pain or myalgia.","journal-title":"Int J Impot Res"},{"key":"ref=32","first-page":"407","volume":"38","author":"Huang S.A.","year":"2013","unstructured":"Huang SA, Lie JD. Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction.","journal-title":"P"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/sj.ijir.3901424","volume":"17","author":"Rodriguez J.J.","year":"2005","unstructured":"Rodriguez JJ, Al Dashti R, Schwarz ER. Linking erectile dysfunction and coronary artery disease.","journal-title":"Int J Impot Res"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0735-1097(00)01114-1","volume":"37","author":"Andrews N.P.","year":"2001","unstructured":"Andrews NP, Husain M, Dakak N, Quyyumi AA. Platelet inhibitory effect of nitric oxide in the human coronary circulation: impact of endothelial dysfunction.","journal-title":"J Am Coll Cardiol"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"S314","DOI":"10.2337\/dc09-S330","volume":"32","author":"Versari D.","year":"2009","unstructured":"Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S. Endothelial dysfunction as a target for prevention of cardiovascular disease.","journal-title":"Diabetes Care"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00345-006-0128-5","volume":"24","author":"Shabsigh R.","year":"2006","unstructured":"Shabsigh R, Stone B. Understanding the needs and objectives of erectile dysfunction patients.","journal-title":"World J Urol"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00006842-199807000-00011","volume":"60","author":"Araujo A.B.","year":"1998","unstructured":"Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB. The relationship between depressive symptoms and male erectile dysfunction: Cross-sectional results from the massachusetts male aging study.","journal-title":"Psychosom Med"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/ijir.2011.32","volume":"23","author":"Jeong J.Y.","year":"2011","unstructured":"Jeong JY, Lee SK, Kang YW, Jang SN, Choi YJ, Kim DH. Relationship between ED and depression among middle-aged and elderly men in Korea: Hallym aging study.","journal-title":"Int J Impot Res"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.31887\/DCNS.2002.4.1\/bbondy","volume":"4","author":"Brigitta B.","year":"2002","unstructured":"Brigitta B. Pathophysiology of depression and mechanisms of treatment.","journal-title":"Dialogues Clin Neurosci"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1602\/neurorx.2.4.590","volume":"2","author":"Schechter L.E.","year":"2005","unstructured":"Schechter LE, Ring RH, Beyer CE. Innovative approaches for the development of antidepressant drugs: Current and future strategies.","journal-title":"NeuroRx"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.physbeh.2004.08.018","volume":"83","author":"Hull E.M.","year":"2004","unstructured":"Hull EM, Muschamp JW, Sato S. Dopamine and serotonin: Influences on male sexual behavior.","journal-title":"Physiol Behav"},{"key":"ref=42","first-page":"1245","volume":"159","author":"Trindade E.","year":"1998","unstructured":"Trindade E, Menon D, Topfer LA, Coloma C. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: A meta-analysis.","journal-title":"CMAJ"},{"key":"ref=43","author":"Gartlehner G.","year":"2011","unstructured":"Gartlehner G, Hansen RA, Reichenpfader U.","journal-title":"Drug class review: second-generation antidepressants: Final update 5 report"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1573399811666150223123053","volume":"11","author":"De Long N.E.","year":"2015","unstructured":"De Long NE, Stepita RA, Taylor VH, Holloway AC. Major depressive disorder and diabetes: Does serotonin bridge the gap?","journal-title":"Curr Diabetes Rev"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/NDT.S5453","volume":"5","author":"Howland R.H.","year":"2009","unstructured":"Howland RH. Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/0976-500X.72369","volume":"1","author":"Manikandan S.","year":"2010","unstructured":"Manikandan S. Agomelatine: A novel melatonergic antidepressant.","journal-title":"J Pharmacol Pharmacother"},{"key":"ref=47","first-page":"10","volume":"8","author":"Sansone R.A.","year":"2011","unstructured":"Sansone RA, Sansone LA. Agomelatine: A novel antidepressant.","journal-title":"Innov Clin Neurosci"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3928\/02793695-20070601-05","volume":"45","author":"Howland R.H.","year":"2007","unstructured":"Howland RH. Agomelatine: a novel atypical antidepressant.","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4088\/PCC.v06n0403","volume":"6","author":"Stahl S.M.","year":"2004","unstructured":"Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4088\/JCP.0706e03","volume":"67","author":"Nutt D.J.","year":"2006","unstructured":"Nutt DJ. The role of dopamine and norepinephrine in depression and antidepressant treatment.","journal-title":"J Clin Psychiatry"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4088\/JCP.12m08000","volume":"74","author":"Grunebaum M.F.","year":"2013","unstructured":"Grunebaum MF, Keilp JG, Ellis SP. SSRI bupropion effects on symptom clusters in suicidal depression: post hoc analysis of a randomized clinical trial.","journal-title":"J Clin Psychiatry"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.psc.2016.04.006","volume":"39","author":"Clayton A.H.","year":"2016","unstructured":"Clayton AH, Alkis AR, Parikh NB, Votta JG. Sexual dysfunction due to psychotropic medications.","journal-title":"Psychiatr Clin North Am"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004850-199512004-00004","volume":"10","author":"de Boer T.","year":"1995","unstructured":"de Boer T. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission.","journal-title":"Int Clin Psychopharmacol"},{"key":"ref=54","first-page":"CD006528","author":"Watanabe N.","year":"2011","unstructured":"Watanabe N, Omori IM, Nakagawa A. Mirtazapine other antidepressive agents for depression.","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.genhosppsych.2012.08.008","volume":"35","author":"Simopoulos E.F.","year":"2013","unstructured":"Simopoulos EF, Trinidad AC. Male erectile dysfunction: Integrating psychopharmacology and psychotherapy.","journal-title":"Gen Hosp Psychiatry"},{"key":"ref=56","unstructured":"1159-66, 69, 72."},{"key":"ref=57","first-page":"S28","volume":"5","author":"Barada J.H.","year":"2003","unstructured":"Barada JH. Optimizing outcomes of oral therapy for patients with erectile dysfunction.","journal-title":"Rev Urol"},{"key":"ref=58","first-page":"CD003382","author":"Taylor M.J.","year":"2013","unstructured":"Taylor MJ, Rudkin L, Bullemor\u2010Day P, Lubin J, Chukwujekwu C, Hawton K. Strategies for managing sexual dysfunction induced by antidepressant medication.","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3810\/pgm.2014.03.2744","volume":"126","author":"Clayton A.H.","year":"2014","unstructured":"Clayton AH, Croft HA, Handiwala L. Antidepressants and sexual dysfunction: Mechanisms and clinical implications.","journal-title":"Postgrad Med"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/20786204.2009.10873868","volume":"51","author":"Outhoff K.","year":"2009","unstructured":"Outhoff K. Antidepressant-induced sexual dysfunction.","journal-title":"S Afr Fam Pract"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/150881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T17:45:56Z","timestamp":1692726356000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/150881\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,19]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,12,19]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450118666170315110902","relation":{},"ISSN":["1389-4501"],"issn-type":[{"type":"print","value":"1389-4501"}],"subject":[],"published":{"date-parts":[[2018,12,19]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2016-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}